Abnormal Uterine Bleeding in Pre-Menopausal Women

Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guideli...

Full description

Saved in:
Bibliographic Details
Published inJournal of obstetrics and gynaecology Canada Vol. 35; no. 5; pp. 473 - 475
Main Authors Singh, Sukhbir, MD, Best, Carolyn, MD, Dunn, Sheila, MD, Leyland, Nicholas, MD, Wolfman, Wendy Lynn, MD
Format Journal Article
LanguageEnglish
French
Published Netherlands Elsevier Inc 01.05.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. Objective To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Methods Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. Results This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Conclusions Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Evidence Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Benefits, harms, and costs Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered.
AbstractList Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. Objective To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Methods Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. Results This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Conclusions Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Evidence Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Benefits, harms, and costs Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered.
Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered.
Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered.
BACKGROUNDAbnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem.OBJECTIVETo provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age.OUTCOMESOutcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB.METHODSMembers of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC.RESULTSThis document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition.CONCLUSIONSAbnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions.EVIDENCEPublished literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.VALUESThe quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table).BENEFITS, HARMS, AND COSTSImplementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered.
Author Leyland, Nicholas, MD
Dunn, Sheila, MD
Best, Carolyn, MD
Wolfman, Wendy Lynn, MD
Singh, Sukhbir, MD
Author_xml – sequence: 1
  fullname: Singh, Sukhbir, MD
– sequence: 2
  fullname: Best, Carolyn, MD
– sequence: 3
  fullname: Dunn, Sheila, MD
– sequence: 4
  fullname: Leyland, Nicholas, MD
– sequence: 5
  fullname: Wolfman, Wendy Lynn, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23756279$$D View this record in MEDLINE/PubMed
BookMark eNqFkD1PwzAQQD0UUQr8BFBHGAJ3cR03C6hUfEkgkKBitBznggyJXewGiX9P-gEDC5Ol07t38huwnvOOGDtAOEHA7PQJJWCSYsaPUBxzyHmeyB7b-R332SDGNwAhucy3WT_lUmSpzHcYTgrnQ6Pr4WxBwToaXtREpXWvQ-uGj4GSe3J-rtvYIS--IbfHtipdR9rfvLtsdnX5PL1J7h6ub6eTu8SMUlgkkqdQFlBVWOB4NAYD45RA6LwqCy7HWiM3KGAkNFaQmqzISiKU0phcZwYLvsuO1t558B8txYVqbDRU19qRb6NCnkkBGce8Q8UaNcHHGKhS82AbHb4UgloWUqtCaplCoVCrQkp2e4ebE23RUPm79ZOnA87XAHUf_bQUVDSWnOkCBTILVXr774mzPwZTW2eNrt_pi-Kbb4PrKipUMVWwliwdKFYGyb8Bu0iMkg
CitedBy_id crossref_primary_10_1111_jog_15226
crossref_primary_10_1097_AOG_0000000000001529
crossref_primary_10_1007_s40264_021_01072_0
crossref_primary_10_15591_mtp_2014_063
crossref_primary_10_5812_ircmj_60508
crossref_primary_10_16948_zktipb_292821
crossref_primary_10_1016_j_jogc_2020_06_012
crossref_primary_10_1016_j_ajog_2022_03_025
crossref_primary_10_1016_j_jogoh_2017_07_005
crossref_primary_10_1097_GCO_0000000000000609
crossref_primary_10_1016_j_medcli_2021_02_006
crossref_primary_10_1016_j_ajog_2017_12_206
crossref_primary_10_1016_j_medcle_2021_02_009
crossref_primary_10_1007_s13224_014_0641_1
crossref_primary_10_1016_j_jmig_2018_04_013
crossref_primary_10_1111_jog_15669
crossref_primary_10_1016_j_vph_2017_05_001
crossref_primary_10_1186_s13048_018_0420_1
crossref_primary_10_18370_2309_4117_2021_62_64_74
crossref_primary_10_28982_josam_7934
crossref_primary_10_9778_cmajo_20190170
crossref_primary_10_1016_j_jpag_2016_09_012
crossref_primary_10_17116_repro20212702156
crossref_primary_10_1016_j_jogc_2016_09_063
crossref_primary_10_1007_s00404_015_3868_x
crossref_primary_10_1185_03007995_2014_982246
crossref_primary_10_1155_2019_8910374
crossref_primary_10_1371_journal_pone_0229123
crossref_primary_10_1166_sam_2023_4595
crossref_primary_10_21518_2079_701X_2022_16_5_32_39
crossref_primary_10_1111_bjh_18291
crossref_primary_10_1155_2019_8598152
crossref_primary_10_1016_S1701_2163_15_30338_8
crossref_primary_10_1097_AOG_0000000000001031
crossref_primary_10_1016_j_jogc_2016_09_067
crossref_primary_10_14442_generalist_36_237
crossref_primary_10_1016_j_jogc_2018_10_002
crossref_primary_10_1080_13625187_2021_1925881
crossref_primary_10_1016_j_jpag_2014_12_012
crossref_primary_10_3390_diagnostics10110884
crossref_primary_10_1016_j_ajog_2016_06_006
crossref_primary_10_1007_s13224_016_0925_8
crossref_primary_10_1007_s11239_024_03006_w
crossref_primary_10_1016_j_bpobgyn_2016_09_009
crossref_primary_10_1016_j_jogc_2015_11_005
crossref_primary_10_5005_jp_journals_10032_1117
crossref_primary_10_4103_amhs_amhs_60_23
crossref_primary_10_1007_s00129_022_05022_4
crossref_primary_10_1016_j_jogc_2019_02_002
crossref_primary_10_1016_j_ygyno_2023_05_061
crossref_primary_10_1089_jwh_2016_6155
crossref_primary_10_17116_onkolog2020906134
crossref_primary_10_17116_rosakush201818462
crossref_primary_10_1016_j_jogc_2018_12_006
crossref_primary_10_1016_j_jogc_2018_12_007
crossref_primary_10_4103_jfmpc_jfmpc_514_20
crossref_primary_10_1080_13645706_2021_1910312
crossref_primary_10_1093_humupd_dmz051
crossref_primary_10_1016_j_jogc_2022_07_002
crossref_primary_10_1080_13645706_2018_1467459
crossref_primary_10_7863_ultra_15_12017
crossref_primary_10_1007_s00404_016_4043_8
crossref_primary_10_1016_j_bpobgyn_2017_01_001
crossref_primary_10_18370_2309_4117_2019_47_8_12
crossref_primary_10_1016_j_jogc_2018_11_017
crossref_primary_10_1016_j_jogc_2018_04_023
crossref_primary_10_7759_cureus_21839
crossref_primary_10_1016_j_jogc_2018_04_024
crossref_primary_10_1080_09513590_2017_1417376
crossref_primary_10_18410_jebmh_2020_222
crossref_primary_10_1016_j_jogc_2019_04_003
crossref_primary_10_1186_s12905_024_03047_6
crossref_primary_10_1371_journal_pone_0217579
crossref_primary_10_26442_2079_5696_2018_2_14_18
crossref_primary_10_1093_fampra_cmx050
crossref_primary_10_18229_kocatepetip_1105749
crossref_primary_10_4236_ojog_2017_75053
crossref_primary_10_4236_ojog_2017_73033
crossref_primary_10_1016_S1701_2163_15_30288_7
crossref_primary_10_1371_journal_pone_0226992
crossref_primary_10_1016_j_medre_2017_10_002
crossref_primary_10_1097_PGP_0000000000000569
crossref_primary_10_1007_s13224_017_1050_z
crossref_primary_10_1016_j_jogc_2018_07_016
crossref_primary_10_1111_1471_0528_15388
ContentType Journal Article
Contributor Dunn, Sheila
Singh, Sukhbir
Wolfman, Wendy
Best, Carolyn
Potestio, Frank
Marcoux, Violaine
Rittenberg, David
Leyland, Nicholas
Heywood, Mark
Menard, Chantal
Awadalla, Alaa
Allaire, Catherine
Lemyre, Madeleine
Contributor_xml – sequence: 1
  givenname: Nicholas
  surname: Leyland
  fullname: Leyland, Nicholas
  organization: North York ON
– sequence: 2
  givenname: Wendy
  surname: Wolfman
  fullname: Wolfman, Wendy
  organization: Toronto ON
– sequence: 3
  givenname: Catherine
  surname: Allaire
  fullname: Allaire, Catherine
  organization: Vancouver BC
– sequence: 4
  givenname: Alaa
  surname: Awadalla
  fullname: Awadalla, Alaa
  organization: Winnipeg MB
– sequence: 5
  givenname: Carolyn
  surname: Best
  fullname: Best, Carolyn
  organization: Toronto ON
– sequence: 6
  givenname: Sheila
  surname: Dunn
  fullname: Dunn, Sheila
  organization: Toronto ON
– sequence: 7
  givenname: Mark
  surname: Heywood
  fullname: Heywood, Mark
  organization: Vancouver BC
– sequence: 8
  givenname: Madeleine
  surname: Lemyre
  fullname: Lemyre, Madeleine
  organization: Quebec QC
– sequence: 9
  givenname: Violaine
  surname: Marcoux
  fullname: Marcoux, Violaine
  organization: Ville Mont-Royal QC
– sequence: 10
  givenname: Chantal
  surname: Menard
  fullname: Menard, Chantal
  organization: Ottawa ON
– sequence: 11
  givenname: Frank
  surname: Potestio
  fullname: Potestio, Frank
  organization: Thunder Bay ON
– sequence: 12
  givenname: David
  surname: Rittenberg
  fullname: Rittenberg, David
  organization: Halifax NS
– sequence: 13
  givenname: Sukhbir
  surname: Singh
  fullname: Singh, Sukhbir
  organization: Ottawa ON
Copyright Society of Obstetricians and Gynaecologists of Canada
2013 Society of Obstetricians and Gynaecologists of Canada
Copyright_xml – notice: Society of Obstetricians and Gynaecologists of Canada
– notice: 2013 Society of Obstetricians and Gynaecologists of Canada
CorporateAuthor CLINICAL PRACTICE – GYNAECOLOGY COMMITTEE
CorporateAuthor_xml – name: CLINICAL PRACTICE – GYNAECOLOGY COMMITTEE
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/S1701-2163(15)30939-7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 475
ExternalDocumentID 10_1016_S1701_2163_15_30939_7
23756279
S1701216315309397
1_s2_0_S1701216315309397
Genre Journal Article
Practice Guideline
GroupedDBID 0R
1-
1P
457
AAIAV
AALRI
AAXUO
ACGFS
AEVXI
AFRHN
AFTJW
AGHFR
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
EBS
EJD
F5P
FDB
FO
GX1
O9-
OK1
OQ.
PH
ROL
SJN
Z5R
.1-
.FO
0R~
1P~
PH~
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c420t-7320db0ff1b18480c082e05a9fdb378aa13c15045a1f02c6b6dee177cc9a6c1b3
ISSN 1701-2163
IngestDate Fri Aug 16 08:48:39 EDT 2024
Thu Sep 26 23:32:41 EDT 2024
Sat Sep 28 07:57:43 EDT 2024
Sat Apr 29 22:45:50 EDT 2023
Thu Aug 18 17:14:57 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords endometrial ablation
heavy menstrual bleeding
Menorrhagia
abnormal uterine bleeding
hysterectomy
menorrhagia
Language English
French
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c420t-7320db0ff1b18480c082e05a9fdb378aa13c15045a1f02c6b6dee177cc9a6c1b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
PMID 23756279
PQID 1367506319
PQPubID 23479
PageCount 3
ParticipantIDs proquest_miscellaneous_1367506319
crossref_primary_10_1016_S1701_2163_15_30939_7
pubmed_primary_23756279
elsevier_sciencedirect_doi_10_1016_S1701_2163_15_30939_7
elsevier_clinicalkeyesjournals_1_s2_0_S1701216315309397
PublicationCentury 2000
PublicationDate 2013-05-01
PublicationDateYYYYMMDD 2013-05-01
PublicationDate_xml – month: 05
  year: 2013
  text: 2013-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of obstetrics and gynaecology Canada
PublicationTitleAlternate J Obstet Gynaecol Can
PublicationYear 2013
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0057379
Score 2.283773
Snippet Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to...
Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will...
BACKGROUNDAbnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 473
SubjectTerms abnormal uterine bleeding
endometrial ablation
Female
heavy menstrual bleeding
Humans
hysterectomy
Menorrhagia
Obstetrics and Gynecology
Premenopause
Uterine Hemorrhage - diagnosis
Uterine Hemorrhage - therapy
Title Abnormal Uterine Bleeding in Pre-Menopausal Women
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1701216315309397
https://dx.doi.org/10.1016/S1701-2163(15)30939-7
https://www.ncbi.nlm.nih.gov/pubmed/23756279
https://search.proquest.com/docview/1367506319
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbEJiFeEL8ZAxQkkEAow47juHkcaGNC3XhoK_XNsh2bVlTp1LQP3V_POXacTVAxeImiKGcrd5e775LzZ4TeWlZKm1uWVpTbNK9UmQKqxynDuYIEm5W6JXs-vyjOJvm3KZv2m3G2q0vW6khf_XFdyf9YFa6BXd0q2X-wbBwULsA52BeOYGE43srGx6p2kHPx0e3L4OCiWvhk1PaGr0zqqMAv5aaBW1qqhR1QdKnA1o6q3xM2_9jW0mhPztSyF8TQPYKxZ76Z5-dMzWNj72fT9O0j2-hvHToezcx8EQcZmm3XTgl-6GrrG98eyLVOvxAuOSZpRkKICvHU048Ev2HXgmPuNy0JeTb3O6b8FsL914RRHNrxVbF3gEpwScuU93mr-1d_8V2cToZDMT6Zju-g_YyXzFXhX6ex14dxT7oYx-yXcn3qJ3pP2IcwyS6QsqsIacHI-AG6H0yXHHuXeIj2TZ3Y1SN09zy0SjxGpHOOJDhH0jlHMq-Tm86RtM7xBE1OT8ZfztKwP0aq8wyvU04zXClsLVFQpw-wBjhnMJOlrRTlAykJ1YD3cyaJxZkuVFEZQzjXupSFJoo-RXv1sjbPUVJJyc2g0IYblWtjlbSWamklpUbarDxAR51CxKWnQRGxP9BpUDgNCsJEq0HBDxDv1Ca6Nb6QlUwTXp9GENFkAntpJwyp14mC5CBKBhTo0Z0AD_nbpG86AwmIku7Xl6zNcgOTUSiMAY0TeJJn3nLxOTLKoQjg5YtbSB-ie_178BLtrVcb8wpQ6Vq9bj3uF078iNo
link.rule.ids 315,786,790,27957,27958
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abnormal+uterine+bleeding+in+pre-menopausal+women&rft.jtitle=Journal+of+obstetrics+and+gynaecology+Canada&rft.au=Singh%2C+Sukhbir&rft.au=Best%2C+Carolyn&rft.au=Dunn%2C+Sheila&rft.au=Leyland%2C+Nicholas&rft.date=2013-05-01&rft.issn=1701-2163&rft.volume=35&rft.issue=5&rft.spage=473&rft.epage=475&rft_id=info:doi/10.1016%2FS1701-2163%2815%2930939-7&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F17012163%2FS1701216313X52004%2Fcov150h.gif